Ekkehard Eigendorff

Bad Berka, TH, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Shades of insulinoma one century after first extensive evaluation by Wilder and colleagues; a figurative review between light and dark.

Shades of insulinoma one century after first extensive evaluation by Wilder and colleagues; a figurative review between light and dark.

Journal: Reviews in endocrine & metabolic disorders

Published: May 26, 2026

Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial.

Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial.

Journal: Lancet (London, England)

Published: August 02, 2024

Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer.

Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer.

Journal: The New England journal of medicine

Published: June 05, 2023

Efficacy of Pazopanib With or Without Gemcitabine in Patients With Anthracycline- and/or Ifosfamide-Refractory Soft Tissue Sarcoma: Final Results of the PAPAGEMO Phase 2 Randomized Clinical Trial.

Efficacy of Pazopanib With or Without Gemcitabine in Patients With Anthracycline- and/or Ifosfamide-Refractory Soft Tissue Sarcoma: Final Results of the PAPAGEMO Phase 2 Randomized Clinical Trial.

Journal: JAMA oncology

Published: December 23, 2020

Chronic Myelogenous Leukemia

Chronic Myelogenous Leukemia

Journal: Deutsche medizinische Wochenschrift (1946)

Published: September 11, 2018

Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML.

Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML.

Journal: Leukemia

Published: January 31, 2018

Cementless Total Hip Arthroplasty in Primary Myelofibrosis - a Case Report.

Cementless Total Hip Arthroplasty in Primary Myelofibrosis - a Case Report.

Journal: Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca

Published: August 16, 2017

Surgery for colorectal cancer in elderly patients: how can we improve outcome?

Surgery for colorectal cancer in elderly patients: how can we improve outcome?

Journal: Journal of cancer research and clinical oncology

Published: December 29, 2016

Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML.

Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML.

Journal: Leukemia

Published: September 27, 2016

Role of comorbidity on outcome of head and neck cancer: a population-based study in Thuringia, Germany.

Role of comorbidity on outcome of head and neck cancer: a population-based study in Thuringia, Germany.

Journal: Cancer medicine

Published: July 02, 2016

Which is the most suitable lymph node predictor for overall survival after primary surgery of head and neck cancer: pN, the number or the ratio of positive lymph nodes, or log odds?

Which is the most suitable lymph node predictor for overall survival after primary surgery of head and neck cancer: pN, the number or the ratio of positive lymph nodes, or log odds?

Journal: Journal of cancer research and clinical oncology

Published: November 18, 2015

Acute leukemia in adults

Acute leukemia in adults

Journal: Der Pathologe

Published: August 29, 2015

Showing 1-12 of 17

Last Updated: 09/26/2026